1 December 2009 in Obstetrics & Gynecology
To compare the effectiveness of transobturator tape with tension-free vaginal tape (TVT) in terms of objective cure of stress urinary incontinence (SUI) at 12 months postoperatively. Women with SUI were randomly allocated to either transobturator tape or TVT procedures and reviewed at 12 months after surgery. The primary outcome was objective evidence of "cure," evaluated by standardized pad test (cure defined as less than 1 g urine leaked). Other outcomes included complications, subjective cure, incontinence-related quality of life, return to usual sexual activity, and satisfaction with surgery. Primary analysis compared the proportion of patients in each group who were cured at 12-month follow-up. A total of 199 women participated (94 in the transobturator tape group, 105 in the TVT group). Sixty-eight women (81%) in the transobturator tape group were cured, compared with 67 (77%) in the TVT group (relative risk 1.05, 95% confidence interval 0.90-1.23, P=.577). On vaginal examination, the tape was palpable for 68 women (80%) in the transobturator tape group and for 24 (27%) in the TVT group (relative risk 0.22, 95% confidence interval 0.13-0.37, P<.001). More women in the transobturator tape group experienced groin pain during vaginal palpation (13 [15%] in the transobturator tape group and five [6%] in the TVT group, P=.044). Quality of life improved significantly from baseline in both groups (30-point improvement in IIQ-7 score for both groups). At 12 months, the majority of women had minimal leakage and their quality of life had improved significantly, but differences were not observed between groups. The presence of palpable tape, particularly among the transobturator tape group, is concerning; longer follow-up is needed to determine whether this outcome leads to extrusion or resolves over time. ClinicalTrials.gov, www.clinicaltrials.gov, NCT00234754. I.
15 December 2015 in International Urogynecology Journal
30 July 2010 in BMC Health Services Research
TGthe CPN Collaborative Group
the CPN Collaborative Group
+1
Background: For ethical approval of a multicentre study in Canada, investigators must apply separately to individual Research Ethics Boards (REBs). In principle, the protection of human research subjects is of utmost importance. However, in practice, the process of multicentre ethics review can be time consuming and costly, requiring duplication of effort for researchers and REBs. We used our experience with ethical review of The Canadian Perinatal Network (CPN), to gain insight into the Canadian system. Methods: The applications forms of 16 different REBs were abstracted for a list of standardized items. The application process across sites was compared. Correspondence between the REB and the investigators was documented in order to construct a timeline to approval, identify the specific issues raised by each board, and describe how they were resolved. Results: Each REB had a different application form. Most (n = 9) had a two or three step application process. Overall, it took a median of 31 days (range 2-174 days) to receive an initial response from the REB. Approval took a median of 42 days (range 4-443 days). Privacy and consent were the two major issues raised. Several additional minor or administrative issues were raised which delayed approval. Conclusions: For CPN, the Canadian REB process of ethical review proved challenging. REBs acted independently and without unified application forms or submission procedures. We call for a critical examination of the ethical, privacy and institutional review processes in Canada, to determine the best way to undertake multicentre review.
10 December 2015 in Climacteric
Experience of menopause in aboriginal women: a systematic review. . ???aop.label???. doi: 10.3109/13697137.2015.1119112
4 February 2011 in BJOG: An International Journal of Obstetrics & Gynaecology
FGfor the Calgary Women’s Pelvic Health Research Group
for the Calgary Women’s Pelvic Health Research Group
Please cite this paper as: Lier D, Ross S, Tang S, Robert M, Jacobs P, for the Calgary Women’s Pelvic Health Research Group. Trans‐obturator tape compared with tension‐free vaginal tape in the surgical treatment of stress urinary incontinence: a cost utility analysis. BJOG 2011;118:550–556. Objective To conduct an economic evaluation of the use of trans‐obturator tape (TOT) compared with tension‐free vaginal tape (TVT) in the surgical treatment of stress urinary incontinence (SUI) in women. Design Cost utility analysis from public‐payer perspective, conducted alongside a randomised clinical trial (RCT). Setting Health services provided in Alberta, Canada. Population A total of 194 women who participated in the RCT, followed to 1 year from surgery. Methods Data collected on all women in the RCT, over 12 months following surgery. Comparisons undertaken between RCT groups for cost and quality‐adjusted life‐years (QALYs). Multiple imputation used for the 10% missing data. Bootstrapping used to account for sampling uncertainty. One‐way sensitivity analysis conducted for productivity loss due to time away from work. Main outcome measures Utility – 15D questionnaire was used to calculate QALYs. Costs over 12 months—from trial data, health provider and provincial ministry of health. Results The TOT group had a non‐significant average saving of $1133 (95% CI −2793; 442), with no difference in average QALYs between groups (95% CI −0.02; 0.01). TOT was cost‐saving in over 80% of bootstrapping replications, over a wide range of willingness‐to‐pay. Conclusion The bootstrapping replication results suggest that TOT could be cost‐effective compared with TVT in the treatment of SUI. However, these results must be confirmed by longer‐term assessment of clinical and economic outcomes, because of concern that surgical tape palpable at 12 months may lead to vaginal erosion and further treatment.
1 July 2018 in Journal of Obstetrics and Gynaecology Canada